Research Interests: My lab has an active research program in clinical neuroscience of addiction. My approach to clinical science involves the integration of experimental psychopathology, behavioral genetics, and pharmacology. More recently, my laboratory began using neuroimaging methods to complement our research program.
A full list of my publications and presentations can be seen in my CV here.
In the news: Dr. Ray is currently featured in the “Meet the Researcher” series by the Research Society on Alcoholism (RSA) and the Addiction Technology Transfer Center (ATTC) Network. Each quarter RSA and the ATTC Network profile researchers whose work has made some difference in our lives.
Below are some recent representative publications:Ray, L.A., Bujarski, S., MacKillop, J., Courtney, K.E., Monti, P.M., & Miotto, K. (2013). Sensitivity to alcohol among alcohol dependent individuals: the effects of the mu opioid receptor (OPRM1) gene and alcoholism severity. Alcoholism: Clinical and Experimental Research, 37(1), E116-E124.
Ray, L.A., Courtney, K., Hutchison, K.E., MacKillop, J., Galvan, A., & Ghahremani, D. (2013). Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues. Alcoholism: Clinical and Experimental Research, 37 Suppl 1, E116-24.
Ray, L.A., Lunny, K., Bujarski, S., Moallem, N., Krull, J.L., & Miotto, K. (2013). The effects of varenicline on stress-induced and cue-induced craving for cigarettes. Drug and Alcohol Dependence, 131(1-2), 136-142.
Roche, D., Bujarski, S., Moallem, N., Guzman, I., Shapiro, J., & Ray, L.A. (2014). Predictors of smoking lapse in a human laboratory paradigm. Psychopharmacology, 231(14). 2889-2897.
Ray, L.A., Bujarski, S., Squeglia, L.M., Ashenhurst, J.R., & Anton, R. (2014). Interactive effects of OPRM1 and DAT1 genetic variation on subjective responses to alcohol. Alcohol & Alcoholism, 49(3), 261-270.
Courtney, K., Ghahremani, D., London, E.D., & Ray, L.A. (2014). The association between cue reactivity in the precuneus and level of dependence on nicotine and alcohol. Drug and Alcohol Dependence, 141, 21-26.
Bujarski, S. & Ray, L.A. (2014). Subjective response to alcohol and associated craving in heavy drinkers vs. alcohol dependents: An examination of Koob's allostatic model in humans. Drug and Alcohol Dependence, 140, 161-167.
L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A., &
London, E.D. (2014). Varenicline, low dose naltrexone, and their
combination for heavy drinking smokers: Human laboratory findings.
Ray, L.A., Courtney, K., Ghahremani, D., Miotto, K., Brody, A. & London, E.D. (2014). Varenicline, naltrexone, and their combination for heavy drinking smokers: Preliminary neuroimaging findings. American Journal of Drug and Alcohol Abuse.
Ray, L.A., Roche, D., Heinzerling, K., & Shoptaw, S. (2014). Opportunities for the development of neuroimmune therapies in addiction. International Review of Neurobiology.